Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Liver Carcinoma”

1,345 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,345 results

Testing effectiveness (Phase 2)Study completedNCT02400788
What this trial is testing

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Yakult Honsha Co., LTD 179
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Not applicableStudy completedNCT01666145
What this trial is testing

Advanced Image Guidance Utilized in Liver Surgery

Who this might be right for
Carcinoma, Hepatocellular
Wake Forest University Health Sciences 14
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Ended earlyNCT01126866
What this trial is testing

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

Who this might be right for
Colorectal Carcinoma
National Center for Tumor Diseases, Heidelberg 35
Early research (Phase 1)Ended earlyNCT00828594
What this trial is testing

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 130
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Large-scale testing (Phase 3)UnknownNCT04797884
What this trial is testing

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
THERABIONIC INC. 166
Testing effectiveness (Phase 2)Study completedNCT00524498
What this trial is testing

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Otsuka Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT04811898
What this trial is testing

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Who this might be right for
Multiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Testing effectiveness (Phase 2)Ended earlyNCT01832857
What this trial is testing

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Who this might be right for
Cancer
Cornerstone Pharmaceuticals 7
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Testing effectiveness (Phase 2)Looking for participantsNCT06954467
What this trial is testing

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT03516071
What this trial is testing

Brivanib in Chinese Patients With Previously Treated Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 90
Early research (Phase 1)UnknownNCT05363722
What this trial is testing

A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 80
Next Page